 NEW YORK, Nov. 12, 2021 PRNewswire -- Mind Medicine MindMed Inc. NASDAQ: MNMD, NEO: MMED, DE: MMQ the Company, a leading biotech company developing psychedelic-inspired therapies, is pleased to announce that its CEO, Robert Barrow, will be speaking at Jefferies 2021 London Healthcare Conference, taking place on November 16-19. Management will be available during the conference for in-person and virtual one-on-one meetings. 